![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Erratum: Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study
Correction to: Eye (2013), 27, 709–715; doi:10.1038/eye.2013.8; published online 1 March 2013 Since the publication of the above article, it has been noted that a line appeared incorrectly between RETREATMENT ...
-
Article
Erratum: Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study
Correction to: Eye (2013) 27, 709–715; doi:10.1038/eye.2013.8; published online 1 March 2013 Since online publication of the above article, the authors have noted that the names of the fifth and ninth authors ...
-
Article
Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study
To evaluate the efficacy and safety of intravitreal ranibizumab in patients with choroidal neovascularisation secondary to pathological myopia (myopic CNV). Data are from a pre-planned, 6-month interim analysis.
-
Article
A case of postoperative candida endophthalmitis